866-997-4948(US-Canada Toll Free)

Allergan, Inc. (AGN) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Jun 2012

Category :

Surgical Equipment

No. of Pages : 41 Pages


Allergan, Inc. (Allergan) is a global healthcare company. It is involved in the development and commercialization of novel pharmaceuticals, over-the-counter (OTC) products, biologics and the medical devices. The company operates in two reportable segments, namely, specialty pharmaceuticals and medical devices. The specialty pharmaceutical segment produces a comprehensive range of pharmaceuticals including both prescription and OTC drugs in the areas of eye care, neuro-modulators, skin care and urologics. The medical devices segment is focused on producing devices in the areas of breast implants, facial aesthetics and obesity intervention products. The company sells its products in over 100 countries through a network of distributors and direct subsidiaries. The key customers of the company are wholesalers, drug stores, pharmacies, hospitals, and medical practitioners. Allergan is headquartered in Irvine, California, the US. 

The company focuses on expanding its product range in the existing and specialty areas through inorganic and organic approaches. This intent is reflected from the companys recent agreements with Moelcular Partners AG and MAP Pharmaceuticals besides development of Botox its lead product its lead product in different indications. The company also concentrates on increasing its presence in emerging markets as indicated by 17% growth in sales to emerging markets.

This report is a source for data, analysis and actionable intelligence on the Allergan, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3
Allergan, Inc. - Business Description 4
Key Facts 6
Allergan, Inc. - Major Products and Services 7
Allergan, Inc. Pipeline Products by Equipment Type 9
Allergan, Inc. Pipeline Products by Development Stage 11
Allergan, Inc. Pipeline Products by Therapy Area 13
Allergan, Inc. Pipeline Products by Trial Phase 15
Brimonidine PLGA Intravitreal Implant 17
Brimonidine PLGA Intravitreal Implant Product Status 17
Brimonidine PLGA Intravitreal Implant Product Description 17
Juvederm VOLUMA 18
Juvederm VOLUMA Product Status 18
Juvederm VOLUMA Product Description 18
Juvederm VOLUMA Product Patent Details 18
Natrelle Style 410 20
Natrelle Style 410 Product Status 20
Natrelle Style 410 Product Description 20
Natrelle Style 410 Product Patent Details 20
ORBERA Intragastric Balloon System 24
ORBERA Intragastric Balloon System Product Status 24
ORBERA Intragastric Balloon System Product Description 24
ORBERA Intragastric Balloon System Product Patent Details 24
Allergan, Inc. - Key Competitors 28
Allergan, Inc. - Key Employees 29
Allergan, Inc. - Key Employee Biographies 30
Allergan, Inc. - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 33
Allergan, Inc., Recent Developments 33
May 02, 2012: Allergan Reports Revenue Of $1.4 Billion In Q1 2012 33
Mar 12, 2012: Allergan Confirms Favorable Decision Of US Federal Court And Issuance Of Permanent Injunction Against Merz 33
Feb 02, 2012: Allergan Reports Revenue Of $1.4 Billion In Q4 2011 34
Dec 23, 2011: Allergan Reassures Patients And Surgeons Of The Quality And Safety Of Its Breast Implant Devices Sold And Distributed Worldwide 35
Nov 24, 2011: Allergan Launches INSPIRA Gel-Filled Breast Implants In Canada 36
Nov 08, 2011: Allergan To Open New Research And Development Facility In New Jersey 36
Oct 26, 2011: Allergan Reports Revenues Of $1.3 Billion In Q3 2011 36
Aug 03, 2011: Allergan Reports Total Revenue Of $1.4 Billion In Q2 2011 38
Jun 22, 2011: Study Analysis Demonstrates Gastric Banding Is Safe And Cost-Effective Weight-Loss Surgery Procedure: Allergan 38
May 04, 2011: Allergan Reports Revenues Of $1.3 Billion In Q1 2011 39

Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Table


Allergan, Inc., Key Facts 1
Allergan, Inc. Key Pipeline Products by Equipment Type 1
Allergan, Inc. Key Pipeline Products by Therapy Area 1
Allergan, Inc. Key Pipeline Products by Development Stage 1
Allergan, Inc. Key Pipeline Products by Trial Phase 1
Allergan, Inc., Key Facts 6
Allergan, Inc., Major Products and Services 7
Allergan, Inc. Number of Pipeline Products by Equipment Type 9
Allergan, Inc. Pipeline Products by Equipment Type 10
Allergan, Inc. Number of Pipeline Products by Development Stage 11
Allergan, Inc. Pipeline Products by Development Stage 12
Allergan, Inc. Number of Pipeline Products by Therapy Area 13
Allergan, Inc. Pipeline Products by Therapy Area 14
Allergan, Inc. Number of Pipeline Products by Trial Phase 15
Allergan, Inc. Pipeline Products by Trial Phase 16
Brimonidine PLGA Intravitreal Implant - Product Status 17
Brimonidine PLGA Intravitreal Implant - Product Description 17
Juvederm VOLUMA - Product Status 18
Juvederm VOLUMA - Product Description 18
Juvederm VOLUMA - Patent Details 18
Natrelle Style 410 - Product Status 20
Natrelle Style 410 - Product Description 20
Natrelle Style 410 - Patent Details 20
ORBERA Intragastric Balloon System - Product Status 24
ORBERA Intragastric Balloon System - Product Description 24
ORBERA Intragastric Balloon System - Patent Details 24
Allergan, Inc., Key Employees 29
Allergan, Inc., Key Employee Biographies 30
Allergan, Inc., Other Locations 31
Allergan, Inc., Subsidiaries 31

List of Chart


Allergan, Inc. Pipeline Products by Equipment Type 9
Allergan, Inc. Pipeline Products by Development Stage 11
Allergan, Inc. Pipeline Products by Therapy Area 13
Allergan, Inc. Pipeline Products by Trial Phase 15

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *